Effects of diethylaminelnitric oxide on blood perfusion and oxygenation in the R323OAc mammary carcinoma
1997

Effects of a Nitric Oxide Donor on Tumor Blood Flow and Oxygenation

Sample size: 13 publication Evidence: moderate

Author Information

Author(s): SQ Shan, GL Rosner, RD Braun, J Hahn, C Pearce, MW Dewhirst

Primary Institution: Duke University Medical Center

Hypothesis

Systemic changes in cardiovascular function induced by DEA/NO administration would lead to alterations in tumour perfusion and oxygenation.

Conclusion

The study found that intravenous injection of DEA/NO decreases mean arterial pressure and heart rate, leading to subsequent decreases in tumour blood flow and oxygenation.

Supporting Evidence

  • DEA/NO reduced mean arterial pressure when given at doses ≥100 nmol kg-1.
  • At doses ≥100 nmol kg-1, DEA/NO reduced tumor blood flow and constricted tumor arterioles.
  • Significant vasomotion in tumor arterioles occurred during hypotension.
  • Intratumoral pO2 dropped significantly after DEA/NO administration.

Takeaway

When a special drug was given to rats, it made their blood pressure drop, which caused less blood and oxygen to reach their tumors.

Methodology

The study used Fischer-344 rats with implanted tumors to measure blood flow and oxygen levels after administering different doses of DEA/NO.

Limitations

The study was conducted on rats, which may not fully represent human responses.

Participant Demographics

Fischer-344 rats weighing 130-180 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication